The ancient weapon seems to be a rare type of iron sword made in the Frankish Empire. While clearing a field on his farm, a ...
Although the vessel had largely rotted away, radiocarbon dating of the wood around some of the rivets and the two charcoal ...
In a southern Norway field, a farmer and his son started clearing stones to prepare for planting. The farmer picked up some ...
BofA Securities reiterates a Buy rating on VIK, with a price target of $35. Analyst Andrew G. Didora highlights VIK's strong ...
In Norse tradition, ship burials were used to honor the dead and give them a permanent resting place underwater. A discovery ...
The clang of hammer on metal rings out across the Danish fjord as sweating blacksmiths work to painstakingly recreate an ...
Viking Therapeutics is pulling up some extra long boats full of reasons the metabolic dysfunction-associated steatohepatitis (MASH) drug VK2809 could be a winner, but executives were mum on exactly ...
Viking Therapeutics (VKTX) stock fell after a conference call discussing data from a successful mid-stage trial for its liver disease therapy VK2809. Read more here.
Viking starts third season in the Great Lakes, with both of its identical expedition ships, the Viking Octantis and ...
After 52 weeks, plasma levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (liver enzymes) were ...
Like the Big Three cruise companies, which have been bragging for months about their record booked position, Viking's bookings are through the roof.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback